RGGGH biochemistry lab reduces patient queues with web portal, bar code system, point-of-care testing, and therapeutic drug ...

A study led by UCL found that individuals with rare diseases were five times more likely to die from Covid-19 than the ...

The World Health Organization and St Jude Children's Research Hospital have kicked off a programme to distribute cancer ...

BMS has reported that the Phase II TRANSCEND FL trial assessing Breyanzi, met its primary endpoint in the marginal zone ...

More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

Q32 Bio has stopped a Phase II trial of its former lead renal disease candidate as it focuses on its alopecia areata ...

T-cell therapy represents a groundbreaking advancement in the field of immuno-oncology. This innovative treatment involves ...

The following highlights showcase the most pivotal, innovative research published across multiple therapeutic areas in ...

Sepsis, a life-threatening organ dysfunction, is responsible for an estimated 1 in 5 deaths globally and 1 in 3 deaths that ...

RFK Jr.’s views on vaccine safety have sparked debate, with some experts saying that his comments are misleading.

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

Biosimilars Market Poised for Rapid Growth, Driven by Advancements in Therapeutics and Expanding Patient AccessPune, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Global Biosimilars Market Size & Growth Analysis: ...